Keen Intelligent Manufacturing: Reaching another important milestone in cooperation
Release time:
2023-11-08
On the afternoon of November 3, 2023, Ms. Hong Shuli, Chairman of Hangzhou Accord International, and Mr. Xie Qingping, Director of Hangzhou Qiushi Hospital, visited Cohen Company to visit and negotiate cooperation.
On the afternoon of November 3, 2023, Ms. Hong Shuli, Chairman of Hangzhou Accord International, and Mr. Xie Qingping, Director of Hangzhou Qiushi Hospital, visited Cohen Company to visit and negotiate cooperation.
In the booth area of ??Keen, Professor Xie showed strong interest in the small joint series of original instruments independently developed by Keen. Professor Xie had a lively discussion with the company's founder, Mr. Su Xihong. Mr. Su introduced the company’s current “star products” in detail to Professor Xie and Ms. Hong, and told the future vision of Cohen Company and the story of its founding. Professor Xie and Ms. Hong are full of expectations for the future prospects of Cohen Company and the cooperation between the two parties!
After the visit, the three parties reached important strategic cooperation on this friendly negotiation:
1. Cooperate to develop a series of finger joint prosthesis products. Professor Xie is hired as the company’s chief R&D leader and chief clinical medical officer;
2. As the designer and developer of finger joint prostheses, Professor Xie will participate in the entire product development cycle and be responsible for clinical verification and academic promotion of future products after they are launched;
3. Hangzhou Accord International will launch an in-depth strategic cooperation with Cohen Company, and will gradually conduct comprehensive and in-depth cooperation in the cultivation of the finger joint prosthesis market, channel expansion, clinical training of small joints, and the joint construction and sharing of the sales team;



Copyright © 2023 Wuxi Keenman Manufacturing Technology Co.,Ltd. All Rights Reserved. www.300.cn wuxi SEO business license